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Abstract 
Context: Attentional bias modification (ABM) procedures is a promising intervention tool for a 
variety of clinical conditions. Objectives: This study provides an updated review of the clinical impact of 
ABM by employing standard meta-analytic procedures to: (a) estimate the average effect size of ABM in 
reducing both attention bias (AB) and symptoms; (b) estimate the average effect size for different conditions 
(e.g., anxiety, depression, substance abuse); (c) test possible variables that may moderate the effect sizes, 
and (d) investigate the relationship between pre-existent AB and the reduction in AB and symptoms. 
Method: We included 43 controlled trials with a total of 2268 participants providing 47 group comparisons 
(i.e., training vs. control condition). Inclusion criteria were: AB was specifically targeted to reduce 
symptomatology and/or emotional vulnerability; participants were randomized to the experimental 
conditions; a control condition (defined as sham training) existed; symptoms were assessed at least post-
intervention; sufficient data were provided to allow effect size estimation. Results: We obtained a small 
overall effect size on symptoms post intervention, g = 0.160, 95% CI = [0.055; 0.265], driven by anxiety 
studies, g = 0.260, 95% CI = [0.132; 0.388], and studies conducted in healthy participants, g = 0.211, 95% 
CI = [0.046; 0.375]; no significant effect sizes were found post intervention for other symptom categories. 
Conclusion: The therapeutic benefit of ABM is rather small for anxiety, while the amount of data for other 
symptom categories is limited. We argue that more efficient, psychometrically sound procedures are needed 
for assessing and modifying AB.  
Key words: attentional bias modification, meta-analysis, anxiety, depression, addictive behaviors.   
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Clinical Efficacy of Attentional Bias Modification Procedures: An Updated Meta-analysis 
Introduction 
In recent years, an extensive body of research on attentional bias modification (ABM) procedures has 
accumulated. The ABM procedures build upon cognitive theories of psychopathology, which assume that 
attentional biases (AB) are critical cognitive mechanisms underlying a wide range of clinical conditions. The 
clinical purpose of ABM procedures is to reduce excessive allocation of attention to disorder-relevant 
information (e.g., threat, negative information or addiction-related material); by targeting this critical 
cognitive process, ABM is expected to reduce symptoms, emotional reactivity or craving (MacLeod & 
Mathews, 2012).  
To date, three experimental paradigms have been used for ABM: visual probe (or dot-probe) task, 
emotional spatial (or visual) cueing task, and visual search task. A common feature of these procedures is 
that they manipulate attention allocation to disorder-relevant stimuli when these compete for attention with 
disorder-incompatible stimuli in such a way that performance on the task benefits from allocating attention 
towards the disorder-incompatible stimuli (Koster, Fox, & MacLeod, 2009).  
Most research so far employed the modified visual probe task (MacLeod, Rutherford, Campbell, 
Ebsworthy, & Holker, 2002). In this task, two stimuli are simultaneously presented for brief durations (e.g., 
500ms) either at one side of the fixation cross (i.e., left/right or up/down). The valence of the stimuli is 
manipulated in that one stimulus has a disorder-congruent valence (e.g., angry facial expression) whereas 
the other has a disorder incongruent valence (e.g., happy or neutral facial expression). Next, a neutral probe 
(e.g., a letter, an asterix or a dot) appears at the location previously occupied by one of the two stimuli (i.e., 
right/left or up/down). Participants either indicate the location of the probe or discriminate between different 
probes (e.g., “E” or “F”) as quickly and accurately as possible. To train attention away from disorder-
relevant stimuli and towards disorder-incompatible stimuli, the target consistently replaces the disorder-
incompatible stimulus during the training phase.  
Other studies used a modified version of the emotional spatial cueing task (Fox, Russo, Bowles, & 
Dutton, 2001; Posner, 1980) to train attention. This task presents an emotional cue in one of two possible 
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locations, followed by a target stimulus either at the cued location or at the alternative location. AB is 
revealed by facilitated target responding when the target is presented at the location of the disorder relevant 
cue or delayed target responding when the target is presented at the opposite location of the disorder-
relevant cue. In the training variant, a benign AB is obtained by having the target stimulus never appear at 
the location previously occupied by a disorder-relevant stimulus (Baert, De Raedt, Schacht, & Koster, 2010; 
Bar-Haim, Morag, & Glickman, 2011).  
Finally, other studies (e.g., Dandeneau, Baldwin, Baccus, Sakellaropoulo, & Pruessner, 2007) used the 
visual search task to manipulate attention. This task involves repeatedly asking the participant to find a 
target disorder-incompatible stimulus (e.g., a smiling face) among distracting disorder-relevant stimuli (e.g., 
frowning faces). The participants are encouraged to find the target stimulus as soon as possible. It is 
assumed that, through repetitive practice, they implicitly learn to overcome their tendency to preferentially 
process disorder-relevant stimuli. Instead, they learn a pattern of attentional selectivity favoring positive 
information.  
Seminal studies suggested that ABM procedures have considerable clinical potential in that training 
efficiently leads to clinical improvement with little time investment of the patient at minimal costs (Amir, 
Beard, Burns, & Bomyea, 2009; Amir, Beard, Taylor, et al., 2009; Schmidt, Richey, Buckner, & Timpano, 
2009). Because of such findings and the fact that ABM can be easily disseminated, several narrative reviews 
have pointed out that ABM has the potential to become an important clinical intervention for the treatment 
and prevention of psychopathology (Bar-Haim, 2010; Browning, Holmes, & Harmer, 2010; Hertel & 
Mathews, 2011; MacLeod & Mathews, 2012). Moreover, three meta-analyses (Beard, Sawyer, & Hofmann, 
2012; Hakamata et al., 2010; Hallion & Ruscio, 2011) examined ABM effects on symptoms and AB change. 
However, two main issues of these syntheses of the ABM literature should be noted: namely, (1) their 
reports are inconsistent, both in terms of change in AB and symptoms, and (2) none of them included any of 
the recent negative findings reported with the ABM, although all of them reported publication bias. We 
briefly discuss each of these limitations below. 
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Limitations of the existing reviews of the ABM clinical efficacy 
1. Inconsistent findings 
Some of the previous meta-analyses indicated large effect sizes for change in AB (Beard, Sawyer, et 
al., 2012; Hakamata et al., 2010), while others indicated small effect sizes (Hallion & Ruscio, 2011). 
Similarly, for change in symptoms, some reported a medium effect size (Hakamata et al., 2010), while 
others indicated a small effect size (Beard, Sawyer, et al., 2012; Hallion & Ruscio, 2011). These incongruent 
findings may be explained in terms of the methodological approach of these meta-analyses. A first issue 
concerns the range of studies included in each of them. For instance, Hakamata et al. (2010) included only 
anxiety studies employing ABM, while Hallion and Ruscio (2011) included only anxiety and depression 
studies employing ABM and/or interpretation bias modification, but investigated the effects of ABM and 
interpretation bias modification mainly together (e.g., without reporting separate effect sizes for ABM’s 
versus interpretation bias modification’s impact on symptoms). This is unfortunate as the different biases 
(AB, interpretation bias) may operate in different ways in psychopathology and there may also be 
differences in the plasticity of these biases by training.  
Beard et al. (2012) included a wide range of samples and symptoms. However, they did not report 
different estimates of ABM effect on symptoms by diagnostic status of participants or symptom category. 
This is problematic because it may be easier to change AB in healthy compared with clinical or analogue 
samples. In addition, although a diversity of clinical conditions have been found to be characterized by AB 
(Bar-Haim, Lamy, Pergamin, Bakermans-Kranenburg, & van IJzendoorn, 2007; Beard & Amir, 2010; 
Brooks, Prince, Stahl, Campbell, & Treasure, 2011; Chapman & Martin, 2011; Field & Cox, 2008; Hertel & 
Mathews, 2011), they present considerable differences in symptoms, etiology, and prognosis, and AB has 
been found to display different particularities as a function of disorder. Therefore, it may play a different 
functional role in different disorders (e.g., Mathews & MacLeod, 2005), meaning that it can be causally 
involved in symptoms, may contribute to the maintenance of symptoms, or may be merely a characteristic of 
the symptoms. Thus, ABM might be more effective for some psychological conditions (e.g., anxiety) than 
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for others. Such information is crucial for clinical applications and may help orienting subsequent research. 
In addition, as AB is thought to be the ABM mechanism of change, it would make sense to consider the pre-
existent AB level when investigating how successful is ABM in inducing the desired changes. However, 
none of the existing quantitative syntheses of ABM literature considered the role of pre-existing AB in 
relationship with change in AB and/or change in symptoms. This could have contributed also to their 
inconsistent findings. 
2. Publication bias 
Previous ABM meta-analyses reported evidence of publication bias for ABM findings. Arguably, this 
limits our understanding of the current state of research on ABM. No wonder that current views on the 
clinical utility of ABM vary widely among researchers and clinicians. Some hold positive views, advocating 
the ABM clinical potential (e.g., Bar-Haim, 2010; Hakamata et al., 2010; MacLeod & Mathews, 2012), 
while others have negative and skeptical views (Emmelkamp, 2012), pointing out that ABM is efficient only 
in laboratory-based studies and there is no robust evidence of ABM efficiency in clinical samples. Several 
additional controlled clinical studies have been reported since the last meta-analyses, many of which 
reported negative results with ABM (e.g., Boettcher, Berger, & Renneberg, 2012; Carlbring et al., 2012; 
Julian, Beard, Schmidt, Powers, & Smits, 2012; Neubauer et al., 2013). Notably, none of the previous meta-
analyses included these recent negative findings. Arguably, including such failures to replicate promising 
findings is critical in assessing the clinical relevance of ABM. Therefore, an updated quantitative review 
with a clinical focus is timely. 
The present study 
This paper is aimed to comprehensively examine the clinical efficacy of ABM, both in terms of 
outcome (i.e., reducing and/or preventing symptoms of subjective distress, dysfunctional behaviors, and 
biological markers of psychopathology) and in terms of the presumed mechanism of change (i.e., AB). To 
this end, we considered studies that trained attention away from disorder relevant stimuli (congruent with the 
theory-specified direction of clinical improvement) and compared this intervention with an adequate control 
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group (i.e., no training of attention). This allowed us to provide a global estimate of ABM effect size on 
symptoms and AB. Second, we aimed to investigate the degree to which ABM yields therapeutic benefits 
for different symptom categories. Third, we aimed to test possible moderators of the ABM effect. Finally, 
we were interested to investigate the relationship between pre-existent AB and the reduction in AB and 
symptoms. 
Based on the potential moderators considered in the previous reviews and on the theoretically-derived 
assumptions about the factors affecting ABM efficacy, we considered the following potential moderators:  
1. Type of psychopathology. Hallion and Ruscio (2011) reported a small ABM effect size for anxiety studies, 
and non-significant effect for depression studies. However, their results reflected the combined effect of 
ABM and interpretation bias modification on symptom reduction. As the number of ABM studies has 
doubled since that time, it is important to examine whether their results can be replicated and extended to 
other types of symptoms (e.g., substance abuse symptoms). In addition, we aim to refine the previous 
reported results (Hakamata et al.; 2010; Hallion & Ruscio, 2011) by examining whether, within anxiety 
studies, the ABM effect varies as function of the different types of anxiety problems.  
2. Clinical status of the sample was not found to be a significant moderator of the ABM effect in previous 
meta-analyses (Hakamata et al., 2010; Hallion & Ruscio, 2011). However, as our sample of ABM studies is 
considerably larger, we aimed to replicate these results. We considered three sample categories: diagnosed 
participants (clinical samples), undiagnosed participants with elevated symptoms (analogue samples), and 
healthy participants who were exposed to a stressor following ABM (as we were interested in the buffering 
role that ABM could play in relation to negative emotional reactivity). Although any protective effect of the 
ABM in healthy participants would be important, it is essential to demonstrate ABM is capable to modify 
AB and symptoms in clinical samples and/or to reduce relapse in recovered samples.  
3. Training methodology. Previous meta-analyses (Beard et al., 2012; Hakamata et al., 2010) reported that 
type of stimuli used for training (linguistic versus pictorial stimuli) and stimuli position during training (top-
bottom versus left-right) significantly moderated the ABM effect on symptoms, with studies using words 
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and top-bottom orientation of the stimuli yielding larger effects. Hallion and Ruscio (2011) as well as Beard 
et al. (2012) reported the number of training sessions to be a significant moderator of change in symptoms 
assessed post-intervention, but not as assessed following an experimental stressor. However, Hakamata et al. 
(2010) did not find the number of session to moderate the ABM impact on symptoms. To clarify the 
potential moderators related to training methodology, we re-examined as moderators the type of stimuli used 
for training as well as number of sessions in a larger sample of studies and with different symptom 
categories. In addition, we considered several other potential moderators: the number of trials per session, 
type of training task, nature of the ABM training (i.e., towards positive versus towards neutral stimuli), 
training setting (i.e., laboratory versus home), and temporal separation of ABM sessions. 
4. Type of outcomes. We considered two clinically important aspects of the ABM outcomes, namely (1) 
primary versus secondary interest variables, and (2) self-report, clinician-rated, and bio-behavioral 
measures. If training attention away from negative information broadly reduces stress reactivity (i.e., 
secondary outcomes) it presumably impacts on primary as well as secondary interest outcomes. Conversely, 
there may be a specific effect depending on the relevance of the training stimuli relative to the specific 
investigated condition: the effect of ABM designed for lowering depressive symptoms, for example, may be 
larger on depression measures (primary outcome) than on general distress or anxiety measures (secondary 
outcome). In addition, treatment change would be more reliable if it is observed on all type of the outcome 
measures (self-report, clinician-rated, and bio-behavioral measures). If the improvement is evident only on 
self-report measures, it could be more liable to demand effects or be less robust. 
5. Participants’ age. Hakamata et al. (2010) reported that participants’ age did not significantly moderate the 
ABM effect. However, there was relatively little variability among studies included in their meta-analysis, 
as most participants were students. The participants’ age in ABM studies has expanded lately considerably, 
with studies conducted on children (e.g., Bar-Haim et al., 2011; Eldar et al., 2012) or older adults (e.g., 
Schoorl, Putman, & Van Der Does, 2013; Sharpe et al., 2012) being added to the field. We treated 
participants’ age as a continuous moderator.  
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We investigated the relationship between AB and symptom change in two ways. First, we examined 
the relation between the pre-existent AB and the reduction in AB and symptoms, respectively, given that the 
reduction in AB is the presumed mechanism of change of ABM interventions. Yet, none of the previous 
meta-analyses considered the role of the pre-existent AB in relation with ABM efficacy. Second, we 
examine the relation between AB change and symptom changes. Previous meta-analyses failed to find a 
statistically significant relationship between reduction in AB and reduction in symptoms following ABM 
(Hakamata et al., 2010; Hallion & Ruscio, 2011). This may be due to the possibility that ABM lowers 
symptoms via AB reduction only in persons with a pre-existing AB, where this could be an important 
selection criteria to enroll in training (see Eldar et al., 2012).  
This meta-analysis has both theoretical and practical implications. From a theoretical point of view, as 
compared to previous meta-analyses in the field, it brings the following new innovations: it includes newer 
studies that failed to replicate the original positive findings with ABM; it assesses the pre-existing bias 
levels; and it looks for differential ABM effect within anxiety studies. All of these have potential to further 
inform the research work in the field. From a practical point of view, this meta-analysis is timely because 
ABM is already marketed to anxiety patients. Therefore, to rigorously guide the clinical practice of 
psychology we need a comprehensive meta-analysis, organized from a theoretical point of view and which 
tries to delineate clear practical implications and future directions of development the clinical utility of 
ABM procedures. 
Method 
Literature search 
Potential relevant studies were identified through a systematic search of the ISI Web of Science, 
Scopus, and Medline databases through July 2013, using the following search terms: “attentional bias 
modification”, and “attention bias” combined with “attentional (re)training” and “experimental 
manipulation”. We also systematically searched the references from the empirical papers, meta-analyses, 
and reviews on the topic.  
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We identified 1231 records (for details see Figure 1). Duplicates were removed and the remaining 
records were screened based on title and abstract. After excluding clearly irrelevant publications, a total of 
86 potential relevant articles were retained for detailed inspection. Their full-texts were reviewed for 
inclusion in the meta-analysis. 
(Insert Figure 1 about here) 
Inclusion criteria 
The following criteria were applied for inclusion in the meta-analysis: (a) the study was designed to 
manipulate AB to reduce symptoms and/or lower emotional vulnerability (in the latter case, to be included a 
study should have included at least one measure of distress); (b) the study assessed clinically-relevant 
symptoms; (c) participants were randomized to training conditions; (d) a control condition (defined as sham 
training) existed; (e) the study was written in English and published/accepted for publication in a peer-
reviewed journal; (f) sufficient data to compute effect size were available. We did not include studies that: 
investigated the effect of other types of cognitive bias modification (e.g., interpretation bias; see Amir, 
Bomyea, & Beard, 2010; Brosan, Hoppitt, Shelfer, Sillence, & Mackintosh, 2011) or used attention 
(re)training to improve attention functioning and not for modifying AB (Dvorkin et al., 2013) or symptoms  
(e.g., Van Bockstaele, Koster, Verschuere, Crombez, & De Houwer, 2012).  
Selection of the comparison groups 
 Some studies included a third group (trained to attend to threat stimuli; e.g., Heeren, Reese, 
McNally, & Philippot, 2012; Klumpp & Amir, 2010), but we focus exclusively on comparing the ABM 
group trained towards the neutral/positive stimuli to the control group. We chose to do this because we were 
specifically interested in the clinical implications of AB reduction rather than in the consequences of 
experimental induction of AB.  
There were two studies that investigated ABM effect using four groups, two experimental and two 
control groups (Browning, Holmes, Charles, Cowen, & Harmer, 2012; Julian et al., 2012). Browning and 
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colleagues (2012) investigated the efficacy of ABM in (1) a training group using pictorial stimuli compared 
with a control group using the same pictorial stimuli, and (2) a training group using linguistic stimuli 
compared with a control group using the same linguistic stimuli. Julian and colleagues (2012) compared a 
typical ABM intervention (involving one experimental and one control group) with an enhanced ABM 
intervention, in which participants in both the training and the control groups did exercise before ABM. We 
extracted two sets of data from each of these studies, contrasting the pictorial ABM group with the pictorial 
control group and the linguistic ABM group with the linguistic control group for Browning et al. (2012), 
while for Julian et al. (2012) we compared typical ABM with the control group, and the enhanced ABM 
with the enhanced control group. Therefore, these two studies were analyzed at the level of their four 
different conditions (which is warranted as each condition contains new participants). 
Two other studies deserve specific consideration here. Eldar and Bar-Haim (2010) investigated ABM 
in a sample of low and high anxious participants randomized to experimental and control conditions. We 
extracted two sets of data, related to the ABM impact on high anxious persons, and low anxious persons, 
respectively. Amir, Taylor, & Donohue (2011) reported findings on an extended sample: the authors had 
reported previously findings from a subsample of it (Amir, Beard, Taylor, et al., 2009). In order to avoid 
data overlap, we used only the data reported for LSAS from Amir et al. (2011). We chose to do this because 
the sample size of Amir et al. (2011) was larger than the sample of their previous study (Amir, Beard, 
Taylor, et al., 2009).  
Coding procedures 
For every eligible study we retained the following variables: study identification data (author, year of 
publication), symptoms category, clinical status of the sample, sample size, participants’ mean age, type of 
ABM procedure, type of stimuli, position of stimuli during training, number of training trials, number of 
ABM sessions, temporal separation of ABM sessions, ABM treatment duration, follow-up interval, and 
outcome measures (see Table 1).  
(Insert Table 1 about here) 
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The dependent variables were classified as follows: 
1. Primary outcomes (or measures of the core symptoms related to the investigated condition) 
versus secondary outcomes (or measures of general distress/nonspecific symptoms). Primary and 
secondary outcome for each symptom category are listed in Appendix A. 
2. Self-report, clinician-rated, and bio-behavioral measures. The same outcomes classified 
previously as being primary or secondary were classified here based on how they were measured 
(for example, for bio-behavioral measures we considered the cortisol level or indicators of heart 
rate variability). Measures included in each of these three categories care listed in Appendix B. 
Statistical analyses 
We calculated Hedges’s g effect sizes for every outcome measure for which sufficient data were 
reported. Hedges’s g in an alternative to Cohen’s d, that corrects for the bias in the estimation of the 
population effect size (Hedges & Olkin, 1985). All the effect sizes were coded such that a positive value of 
Hedges’s g indicated greater improvement in the experimental group compared with the control group. In 
order to investigate the relationship between change in AB and change in symptoms, separate sets of effect 
sizes were compiled to index change in AB and change in symptoms, respectively. In addition, as we were 
interested to investigate the extent to which the pre-existent AB influenced ABM impact on AB and 
symptoms, we computed a third set of effect sizes, reflecting baseline differences in AB between groups1. 
For this third set of data, the effect sizes were coded such that a positive value of AB indicated larger AB in 
the experimental group compared with the control group.  
To compute effect size for change in symptoms, we used the following data: means and standard 
deviations, when available; t values from between group analyses, and sample size; Chi-squared values from 
between group analyses; precise p values, and degrees of freedom from between group analyses. Some of 
                                                          
1
 Although participants were randomized to the experimental groups, some baseline differences in AB existed between groups 
even if they were not always statistically significant. To quantify these differences, we chose to use standardized measures of AB 
(i.e., effect size estimates) because: (1) many studies did not report means and standard deviations for AB in baseline, but only a t 
value or just a p value indicating no statistically significant differences; and (2) different studies used different procedures to 
estimate AB.  
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the studies reported outcome measures post-intervention, following a stressor, and/or at follow-up. We 
calculated separate sets of effect sizes for post-intervention, post-stressor, and follow-up measures (see 
Table 1). For studies reporting multiple outcomes at a given time point, we calculated an average effect size 
based on all the measures reported. We computed an overall estimate of the ABM effect, for which data 
from all symptom categories were taken together. We also computed effect sizes for each symptom category 
separately. 
To compute effect sizes reflecting baseline group differences in AB or change in AB following 
ABM, we used means and standard deviations reported in the original study, if these data were available. 
Otherwise, we used the reported statistical information (i.e., independent t tests or p values and sample size). 
For all sets of the calculated effect sizes we used the random effects model (based on the assumption 
that studies come from populations where the effect sizes varies). To test the assumption that the effect sizes 
included in each data set estimate the same population mean, we used the Q statistic and the I² statistic 
(Borenstein, Hedges, Higgins, & Rothstein, 2009). Q statistic relates the true heterogeneity in effect sizes to 
random error, with statistically significant Q suggesting true heterogeneity in the effect sizes, beyond that 
attributable to error. I² statistic indicates the proportion of the observed variance reflecting real differences in 
the effect sizes. We chose to use both Q and I² given their complementary nature: Q is an inferential statistic, 
but it is sensitive to the number of the studies, while I² is a descriptive statistic, not affected by the number 
of the studies (Borenstein et al., 2009).  
To address publication bias, we calculated a fail-safe N for all the effect size subsets. Fail-safe N 
estimates the number of unpublished studies with effect sizes of zero needed to reduce the computed effect 
size below significance (Rosenthal, 1991). In addition, we generated and visually examined funnel plots, 
which plot standard error for each study (determined by sample size) against the effect size computed for 
that study. Studies with larger samples are expected to cluster toward the top of the plot, as they will yield 
larger and more reliable effect sizes, while studies with smaller sample sizes are expected to be scattered 
more widely around the mean and towards the bottom of the plot, as they will yield smaller effect size and 
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are more susceptible to be affected by error. When publication bias is present, the funnel plot will be 
asymmetrical, with fewer small sample-sized studies that would be predicted falling below the mean effect 
size. In case of an asymmetrical funnel plot, Duval and Tweedie’s trim-and-fill procedure (Duval & 
Tweedie, 2000) estimates the likely number of the missing studies that would correct for the publication 
bias. We used this procedure to adjust the computed effect size and the confidence interval according to the 
estimated number of missing studies, to estimate the corrected effect size. All analyses were run using 
Comprehensive Meta-Analysis, Version 2.2.046 (Borenstein, Hedges, Higgins, & Rothstein, 2005). 
Results 
ABM effect on AB 
Overall change in AB. We computed the overall ABM effect size on bias from data reported in 38 
group comparisons (N = 1685 participants), considering only the data reported post intervention. The results 
showed a medium and statistically significant effect size, g = 0.453, p = 0.000, 95% CI = [0.284; 0.623], 
Q(37) = 111.536, p = 0.000, I² = 66.827. Three outliers were identified, with effect sizes exceeding two 
standard deviations from the average effect size (Heeren et al., 2012; See, MacLeod, & Bridle, 2009; Wells 
& Beevers, 2010). After excluding them, the mean effect size was 0.312, p = 0.003, 95% CI = [0.216; 
0.409], Q(34) = 33.966, p = 0.469, I² = 0.000. For follow-up measurements, the average effect size was non-
significant, g = 0.553, p = 0.137, 95% CI = [-0.177; 1.282], Q(4) = 26.349, p = 0.000, I² = 84.819. 
Change in AB across disorders. The average effect size computed for anxiety studies (18 group 
comparisons, 839 participants) was 0.329, p = 0.000, 95% CI = [0.183; 0.474], Q(17) = 19.304, p = 0.311, I² 
= 11.937. For depression (6 group comparisons, 237 participants), the average effect size was non-
significant, g = 0.217, p = 0.099, 95% CI = [-0.040; 0.475], Q(5) = 2.188, p = 0.823, I² = 0.000. Similarly, 
for pain (2 group comparisons, 72 participants) and for substance abuse (5 group comparisons, 288 
participants) the effect sizes were non-significant (pain: g = 0.202, p = 0.379, 95% CI = [-0.248; 0.651], 
Q(1) = 0.372, p = 0.542, I² = 0.000; substance abuse: g = 0.340, p = 0.070, 95% CI = [-0.027; 0.707], Q(4) = 
8.569, p = 0.70, I² = 53.806). However, the effect size for AB change was significant for healthy 
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participants facing a stressful situation (4 group comparisons, 251 participants), g = 0.378, p = 0.003, 95% 
CI = [0.125; 0.631], Q(3) = 2.370, p = 0.499, I² = 0.000.  
Moderators of the ABM effect on change in AB. Only training setting was found to significantly 
moderate the ABM effect for change in AB in the overall data set, Q(1) = 4.770, p = 0.029, with studies 
conducted in laboratory yielding significant lager effects (g = 0.371, p = 0.000, 95% CI = [0.261; 0.480], 
Q(25) = 24.720, p = 0.478, I² = 0.000) than studies conducted out of the laboratory (g = 0.116, p = 0.259, 
95% CI = [-0.085; 0.317], Q(8) = 4.476, p = 0.812, I² = 0.000).  The same was true for anxiety studies, Q(1) 
= 5.202, p = 0.023, studies conducted in laboratory being found to yield significant larger effect size (g = 
0.407, p = 0.000, 95% CI = [0.254; 0.561], Q(14) = 13.281, p = 0.505, I² = 0.000) compared with studies 
conducted out of the laboratory (g = 0.032, p = 0.824, 95% CI = [-0.251; 0.315], Q(2) = 0.821, p = 0.663, I² 
= 0.000). In addition, in anxiety study subsample, participants’ age significantly moderated the ABM effect 
on bias, with younger participants benefiting more from the intervention (slope = - 0.021, p = 0.01).  
 ABM effect on symptoms 
Overall change in symptoms. We computed the overall ABM effect size on symptoms from data 
reported in 42 group comparisons (N = 1979 participants), considering only the data reported post 
intervention. The results showed a small, yet statistically significant effect size, g = 0.196, p = 0.001, 95% 
CI = [0.085; 0.308], Q(41) = 85.190, p = 0.000, I² = 51.173. Two outliers were identified, with effect sizes 
exceeding two standard deviations from the average effect size (Mathews & MacLeod, 2002; Waters, 
Pittaway, Mogg, Bradley, & Pine, 2013). After excluding them, the mean effect size was 0.160, p = 0.003, 
95% CI = [0.055; 0.265], Q(39) = 70.079, p = 0.002, I² = 44.349. For studies reporting outcome measures 
following a stressor (15 group comparisons, 680 participants), the average effect size was 0.404, p = 0.000, 
95% CI = [0.278; 0.531], Q(14) = 13.789, p = 0.466, I² = 0.000. Two outliers were identified, with effect 
sizes exceeding two standard deviations from the average effect size (Dandeneau et al., 2007, Study 3a & 
3b). After excluding these group comparisons, the average effect size was reduced to 0.375, p = 0.000, 95% 
CI = [0.246; 0.504], Q(12) = 8.794, p = 0.720, I² = 0.000. For studies reporting follow-up measures (12 
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group comparisons, 597 participants), the average effect size was 0.454, p = 0.003, 95% CI = [0.171; 0.738], 
Q(11) = 49.828, p = 0.000, I² = 77.968. However, after excluding three outliers (Browning et al., 2012; 
Heeren et al., 2012; Schoenmakers et al., 2010), the average effect size was reduced to non-significance, g = 
0.227, p = 0.087, 95% CI = [-0.033; 0.488], Q(8) = 19.190, p = 0.014, I² = 58.313. There were not 
statistically significant differences between the overall effect sizes computed for different time points, Q(2) 
= 5.191, p = 0.075.  
Change in symptoms across disorders. We computed separate effect sizes for different disorder 
categories and different time points. Results are shown in Table 2. As shown, ABM yielded reliable effects 
at post-intervention and following a stressor only for healthy and anxious participants. No statistically 
significant effect sizes were obtained for follow-up measures, except for one study conducted in healthy 
participants that had a 2-week follow-up period. 
(Insert Table 2 about here) 
Moderators of the ABM effect on symptom reduction. We ran the moderation analyses based on 
data collected post intervention, and post-stressor, respectively, considering only anxiety studies. We 
decided to limit moderation analysis to these data because (1) the overall ABM effect seemed to be driven 
by anxiety studies and studies conducted in healthy participants, and (2) the low number of studies using 
ABM to reduce symptoms/emotional vulnerability in other participants than anxious individuals precluded 
us for running moderation analyses.  
Categorical moderations are shown in Table 3. When symptoms were measured post intervention, 
ABM yielded a small but significant effect on symptoms in social anxiety, and a medium effect in 
generalized anxiety. The effect sizes for other anxiety disorders (e.g., phobias, post-traumatic stress 
disorder) were not significant. Similarly, studies using the modified dot-probe task as well as those 
conducted in laboratory yielded significant larger effects compared with studies using spatial cueing task, or 
conducted via Internet, out of laboratory (i.e., at home). The effect sizes were significant only for primary 
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outcomes, regardless of the time of measurement (i.e., post intervention or post stressor). No other 
significant categorical moderators were identified. 
(Insert Table 3 about here) 
In terms of continuous moderators, we used meta-regression to test the number of trials per session, 
total number of training sessions, the temporal frequency of training sessions, and participants’ age as 
possible moderators. Only participants’ age was found to significantly moderate the ABM effect when 
symptoms were measured post-intervention, with younger individuals benefiting most from ABM (slope = -
0.034, p = 0.000).   
Relationship between the pre-existent AB, change in AB, and change in symptoms 
In the overall dataset, the pre-existent AB was significantly related to the change in AB, r(34) = .519, 
p = 0.002, and the change in AB correlated significantly with the change in symptoms, r(34) = .342, p = 
0.048. However, there was no relationship between the pre-existent AB and change in symptoms, r(32) = -
.005, p = 0.977. We tested in a mediation model the assumption that the pre-existent AB (predictor) 
influenced symptom reduction (outcome) via change in AB (mediator). For mediation analysis we used 
bootstrapping tests with 1000 re-samples and corrected confidence interval (Preacher & Hayes, 2008). The 
results indicated no significant direct or indirect effects of the pre-existent AB on change in symptoms (for 
the direct effect, 95% CI = [-0.384; 0.181]; for the indirect effect, 95% CI = [-0.039; 0.234]).  
The same results pattern was observed within the anxiety sample of studies, where the pre-existent 
AB correlated strongly with the change in AB, r(18) = .745, p = 0.000, but failed statistical significance 
when related to change in symptoms, r(17) = .313, p = 0.221. Similarly, the correlation between change in 
bias and change in symptoms was non-significant, r(17) = .255, p = 0.324. We did not find any evidence of 
direct or indirect effect of the pre-existent AB on change in symptoms (for the direct effect, 95% CI = [-
0.403; 0.578]; for the indirect effect, 95% CI = [-0.659; 0.949]). 
Publication bias 
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Publication bias for change in symptoms. There was evidence of publication bias in the overall data 
set for change in symptoms as measured post-intervention: fail-safe N was 133, smaller than 5K+10 2. In 
addition, Duval and Tweedie’s trim-and-fill procedure (Duval & Tweedie, 2000) estimated 10 missing 
studies with effect sizes smaller than the mean effect size, which would have reduced the mean effect size to 
non-significance, g = 0.031, 95% CI = [-0.080, 0.147]. However, there was no evidence of publication bias 
in the overall data set for change in symptoms as measured post-stressor: fail-safe N was 127, larger than 
5K+10, and trim-and-fill procedure estimated no missing studies.  
Similarly, for anxiety studies, there was some evidence of publication bias for change in symptoms 
when post intervention data were considered: fail-safe N was 119, and trim-and-fill procedure estimated 3 
missing studies, which would have reduced the effect size to 0.205, 95% CI = [0.072, 0.339]. However, 
when post-stressor data were considered, there was no evidence of publication bias (fail-safe N = 63; no 
missing studies were estimated).  
Publication bias for change in AB. No evidence of publication bias was found for change in AB as 
measured post intervention in the overall data set (fail-safe N was 740, no missing studies were estimated). 
However, in the anxiety studies subset there was some evidence of publication bias: fail-safe N was 101, and 
trim-and-fill procedure 4 missing studies which would have reduced the effect size to 0.229, 95% CI = 
[0.066, 0.393].  
Discussion 
This meta-analysis aimed to assess the clinical utility of ABM procedures in the context of the 
growing literature, as the previous reviews on ABM procedures indicated both inconsistent findings and 
publication bias. For this purpose we performed a quantitative review of studies that aimed to reduce AB via 
an ABM procedure and examined effects on symptoms or features of psychopathology. In an attempt to 
provide a better estimation of the clinical utility of ABM, we included recent studies reporting mixed results 
on ABM. As at the publication time of the previous reviews on the topic such studies were not available, 
                                                          
2
 According to Rosenthal (1991), the computed fail-safe N should be larger than 5K+10, where K is the number of studies included 
in meta-analysis 
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considering all the available data could offer a better view on ABM, possibly correcting for publication bias 
reported in previous meta-analyses. In addition, we aimed to organize the extant empirical evidence to 
delineate clear practical implications and future research directions in ABM field. 
The obtained results indicated that: (1) ABM successfully reduces AB and symptoms/emotional 
vulnerability in anxious individuals and healthy participants; and (2) although the pre-existent AB was 
significantly related to change in AB, and change in AB was positively related with change in symptoms in 
the overall data set (but not in the anxiety subsample of studies), no direct or indirect effect of the pre-
existent AB on the change in symptoms was observed. Therefore, with regard to the clinical utility of ABM, 
existing data indicated a small clinical impact (mainly driven by anxiety studies), with about 58%-62% of 
participants in the control group having more symptoms compared with the average participant in the 
experimental group (McGough & Faraone, 2009). In addition, as change in AB did not mediate the 
relationship between the pre-existent level of AB and change in symptoms, the ABM mechanism of change 
is not fully clear. With respect to publication bias, our results suggested that the small effect size could be 
instable, i.e., several additional studies with negative findings would have reduced the effect size to (almost) 
non-significance. 
These results have two main research and clinical implications. First, although ABM reduced AB 
significantly, we need more powerful ABM procedures, to strengthen the clinical effects of ABM: we 
should strive to improve the existing ABM procedures, and/or to develop and test new theory-driven training 
procedures. Future ABM procedures should be aimed to reliably modify AB in a way that allows and 
promotes generalization of the effect. In addition, they should have greater ecological validity. In this sense, 
researchers should seek for modalities of increasing the requirement of selective attention to be oriented 
away from threat and towards neutral or positive material, for instance by providing more visual stimuli. 
Furthermore, we need training task that are more captivating and engaging for participants. Data from a 
recent study (Beard, Weisberg, & Primack, 2012) showed that participants reported a lower engagement 
with ABM programs compared with interpretation modification programs. The authors pointed out the need 
of improving cognitive bias modification programs’ rationale and credibility. 
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Related to this first implication, the fact that ABM conducted out of the laboratory yielded non-
significant effect seriously threatens the clinical utility of ABM, as this intervention was thought to be an 
efficient, independently implemented, and easily disseminated treatment. It is true that the available 
evidence regarding ABM clinical utility out the laboratory is currently limited, precluding firm conclusions. 
However, future studies should investigate the critical factors involved in ABM efficiency in the laboratory, 
so that ABM efficiency out of the laboratory might be improved.  
The second implication of these results concerns the need to clarify the ABM mechanism of change. 
ABM is thought to work by counteracting AB, a dysfunctional automatic way of allocating attentional 
resources. However, the empirical data seem to not support this assumption. Here we need to be cautious 
provided that the amount of data is still limited. A possible explanation could lie in the way that AB is 
conceptualized and measured. We need to know which component of AB is modified (see Cisler & Koster, 
2010) and we need reliable AB measurements. In terms of the modified AB components, it was suggested 
that ABM works through facilitating disengagement from disorder-relevant material (Heeren, Lievens, & 
Philippot, 2011). However, ABM may also act through a mechanism of attentional avoidance, which could 
later contribute to the long-term maintenance of symptoms (Koster, Baert, Bockstaele, & De Raedt, 2010). 
Future studies should clarify this aspect. In terms of AB measurement, most AB tasks are questionable in 
terms of reliability. For instance, the dot-probe task, one of the most used tasks both for AB assessment, has 
been criticized for poor reliability (Cisler, Bacon, & Williams, 2009; Schmukle, 2005). Therefore, relying on 
it for the purpose of measuring a mechanism of change is less than ideal. Future studies should develop and 
test alternative ways to measure different components of AB in a psychometrically sound manner.  
Several other findings deserve discussion here. First, post-stressor measurements seemed to yield 
somewhat stronger results compared with measurements collected right after training, suggesting that AB 
contributes to the vulnerability for developing psychopathology only in the presence of critical stimuli or 
events. Despite this finding, the follow-up effects of ABM did not yield a significant effect size. However, 
the latter conclusion is still preliminary as fewer studies investigated the long-term effects of ABM. Future 
studies should investigate the extent to which ABM contributes to stable resilience to stressors.  
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Second, the possibility that the small effect size is due to non-specific factors (e.g., demand effects) 
should be kept in mind, especially since the effect sizes were significantly larger for studies conducted in the 
laboratory (compared with studies conducted out of laboratory) and for primary outcomes (compared with 
secondary ones). Although we included only randomized trials and most of them reported that participants 
were blind to randomization and to the purposes of the study, a large part of them did not report if 
experimenters were blind as well, and how the participants and/or experimenters were kept blind throughout 
the study. Future studies should clarify these aspects and researchers should take care to demonstrate that 
ABM effects on AB and symptoms are attributable to the experimental manipulation and not to other 
possible factors by adhering more stringently to standards for randomized clinical trials. 
Interestingly, for anxiety studies, the effect size was statistically significant at post-intervention only 
for clinician-rated measures (although the effect size indicators computed for self-report measures and for 
bio-behavioral measures were significant post-stressor). These results might be explained in terms of the 
participant’s ability to consciously report on the benefits of the ABM post-intervention.  Indeed, ABM is 
thought traditionally to reduce anxiety vulnerability (not anxiety per se).  In support of this view, ABM 
effects on bio-behavioral measures were non-significant post intervention (when no immediate challenge 
was faced), but significant following a stressor. Arguably, participants might be unaware of the beneficial 
ABM effects until they face critical events. However, skilled clinicians might be able to assess change in 
anxiety vulnerability. 
Third, the small effect size we obtained is in line with previous reported findings (Beard et al., 2012; 
Hallion & Ruscio, 2011) and are mostly driven by anxiety studies. However, this result should be interpreted 
with caution, as there are far fewer studies which investigated ABM in other symptom categories than 
studies which employed ABM to reduce anxiety symptoms. There was also evidence of publication bias 
when measurement collected post intervention were considered, both in the overall data set and in anxiety 
subsample effect sizes set. When the trim-and-fill procedure was applied, the estimated ABM effect size 
became non-significant in the overall data set and approached non-significance for anxiety studies, 
suggesting that the small computed effect size may be instable. As such, more randomized clinical trials 
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should be published before meaningful conclusions can be derived. Given the potential problem of 
publication bias, the contribution from studies reporting negative findings/small effect sizes should be 
especially encouraged.  
Fourth, participants’ age significantly moderated the ABM’s impact both on AB and symptoms, with 
younger participants benefiting the most. This may be due to younger participants being more accustomed to 
technology and believe more in the therapeutic potential of a computerized task. Alternatively, AB at 
younger age may be more easily changed compared with adults. Future studies should investigate factors 
that may contribute to ABM efficacy in different age categories.  
Limits and directions for future studies 
The results of this meta-analysis are limited in several ways. First of all, one should notice that many 
of the included studies were anxiety studies conducted in analogue samples and having small sample size. 
Second, the same group of investigators was involved in conducting more than one study. Third, not every 
study included an AB measure, the purported mechanism of change. Even when a measure of AB change 
was included, most times the task used for AB assessment was a modified version of the task used for 
training. As noted elsewhere (e.g., Koster et al., 2009), this does not allow to examine real-world transfer of 
training effects.  
This is the first meta-analytical work that considered specifically the role of the pre-existent AB in 
relation to ABM efficacy. Our mediational analysis indicated no significant involvement of pre-existing bias 
in the response to ABM. However, two main limitations should be made clear. First, because our approach 
of estimating the pre-existing AB relied on contrasting the experimental group with the control group, we 
cannot say for sure that there was a real pre-existing AB in group receiving the intervention compared with 
the control group. To do that, we should have considered the pre-existent AB in both groups relative to zero 
(i.e., the absence of the AB). Second, change in bias was measured at the same time with change in 
symptoms. Consequently, the causal relationship between change in bias and change in symptoms cannot be 
empirically proved. Therefore, our results should be interpreted cautiously. Future experimental studies are 
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needed to specifically investigate the role of the pre-existent AB in relation with change in AB and 
symptoms following ABM, by providing intermediate measurements of AB. 
Conclusions 
 As ABM therapeutic benefits are rather limited, we believe it is clearly premature to speak of ABM 
treatment (see Bar-Haim, 2010; Hakamata et al., 2010). The results of the present work urges for more 
adequately powered, randomized controlled clinical trials, conducted by different research groups, and 
aimed to rigorously assess ABM impact on both AB and symptoms. 
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Table 1. Characteristics of the studies included in meta-analysis 
Study Disorder Sample type Sample 
size 
 Mea
n 
age 
ABM Condition Outcome 
measures 
Hedges' g for change in 
symptoms 
   ABM 
Group 
ACC 
Group 
 Training 
task 
Type of 
stimuli 
Type of 
training 
Stimuli 
presentation 
during 
training 
No. of 
training 
sessions 
No. of 
trials 
per 
sessio
n 
Temporal 
separation 
of ABM 
session (in 
days) 
Training 
setting 
 Post 
intervention 
Post-
stressor 
Follow
-up 
Amir, Beard, 
Burns, et al. 
(2009) 
Anxiety Clinical 14 15 26 dot-
probe 
picture
s 
neutral vertical 8 240 2 lab BDI-II, HAM-
D, HRSA, 
PSWQ, SCID, 
STAI-S, 
STAI-T, 
WDQ  
0.68 - - 
Amir, Beard, 
Taylor, et al. 
(2009) 
Anxiety Clinical 22 22 29 dot-
probe 
words neutral vertical 8 160 2 lab BDI-II, HAM-
D, SCID, 
SDS, SPAI, 
STAI-T 
0.39 - - 
Amir, et al. 
(2011) 
Anxiety Clinical 55 57 31 dot-
probe 
picture
s 
neutral vertical 8 160 2 lab LSAS 0.61 - - 
Amir, et al. 
(2008) 
Anxiety Analogue / 
subclinical 
47 47 19 dot-
probe 
picture
s 
neutral vertical 1 160 not 
applicable 
home speech 
performance, 
STAI-S 
0.17 0.48 - 
Baert, et al. 
(2010) S1 
Depressio
n 
Analogue / 
subclinical 
25 23 20 visual 
cueing 
words positive horizontal 10 220 1 home BDI-II, 
MASQ, 
POMS, RRS 
-0.27 - - 
Baert, et al. 
(2010) S2 
Depressio
n 
Clinical 15 20 42 visual 
cueing 
words positive horizontal 10 220 1 home BDI-II, 
MASQ, 
POMS, RRS 
0.27 - - 
Baert et al. 
(2012) 
- Healthy 
participants 
16 16 27 dot-
probe 
picture
s 
positive horizontal 6 210 1 home HF, LF, 
LF/HF ratio, 
RMSSD 
0.19 0.51 - 
Bar-Haim, et Anxiety Analogue / 18 16 10 visual picture neutral horizontal 2 384 2 lab CDI, STAI-C, 
VAS anxiety, 
-0.2 0.04 - 
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al. (2011) subclinical cueing s VAS 
depression 
Boettcher, et 
al. (2012) 
Anxiety Clinical 33 35 38 dot-
probe 
picture
s 
neutral vertical 10 160 2 home BDI-II, BSI, 
LSAS, SCID, 
SIAS, SPS 
-0.21 - 0.09 
Browning, et 
al. (2012) 
(pictures) 
Depressio
n 
Clinical 16 14 36 dot-
probe 
picture
s 
positive vertical 28 96 0.5 home BDI-II, CAR, 
HAM-D, 
STAI-T 
-0.27 - 1.32 
Browning, et 
al. (2012) 
(words) 
Depressio
n 
Clinical 16 15 41 dot-
probe 
words positive vertical 28 96 0.5 home BDI-II, CAR, 
HAMD, 
STAI-T 
-0.61 - -0.48 
Bunnell, et 
al. (2013) 
Anxiety Clinical 15 16 24 dot-
probe 
picture
s 
neutral vertical 8 160 0.5 lab IST, UCT, 
BARS, BSPS, 
CGI-I, CGI-S, 
BDI-II, 
LSAS-SR, 
SPAI 
0.17 0.04  
Carlbring, et 
al. (2012) 
Anxiety Clinical 40 39 37 dot-
probe 
picture
s 
neutral vertical 8 160 2 home BAI, CGI, 
LSAS, SCID, 
SIAS, SPSQ, 
QOLI 
0.09 - -0.01 
Dandeneau 
& Baldwin 
(2009) 
Low self-
esteem 
Healthy 
participants 
72 72 22 visual 
search  
picture
s 
positive matrix 1 112 not 
applicable 
lab VAS feelings 
of rejection, 
SES, CIQ 
0.16 - - 
Dandeneau, 
et al. (2007) 
S3a 
Low self-
esteem 
Healthy 
participants 
12 13 20 visual 
search  
picture
s 
positive matrix 5 80 1 home School 
abilities self-
esteem, STAI-
S 
- - - 
Dandeneau, 
et al. (2007) 
S3b 
Low self-
esteem 
Healthy 
participants 
11 12 unsp
ecifi
ed 
visual 
search  
picture
s 
positive matrix 5 80 1 home Cortisol index, 
cortisol 
reactivity, 
self-
confidence 
rated by other 
0.53 1.24 - 
Eldar & Bar-
Haim (2010) 
Anxiety Analogue / 
subclinical 
15 15 23 dot-
probe 
picture
s 
neutral horizontal 1 480 not 
applicable 
lab ERP-N2, 
ERP-P2, ERP-
0.82 - - 
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(anxious) P3 
Eldar & Bar-
Haim (2010) 
(non-
anxious) 
- Healthy 
participants 
15 15 23 dot-
probe 
picture
s 
neutral horizontal 1 480 not 
applicable 
lab ERP-P3 0.04 - - 
Eldar, et al. 
(2012) 
Anxiety Clinical 15 15 10 dot-
probe 
picture
s 
neutral horizontal 4 480 unspecified lab Anxiety 
severity scale, 
anxiety 
symptoms 
count, SCID 
0.43 - - 
Field, et al. 
(2007) 
Substance 
abuse 
Analogue / 
subclinical 
20 20 23 dot-
probe 
picture
s 
neutral horizontal 1 960 not 
applicable 
lab Amount of 
beer 
consumed, 
DAQ, VAS 
urge to drink 
0.02 - - 
Field, et al. 
(2009) 
Substance 
abuse 
Analogue / 
subclinical 
24 24 23 dot-
probe 
picture
s 
neutral horizontal 1 896 not 
applicable 
lab Choose to 
smoke, 
amount 
willing to pay, 
delay 
discounting, 
VAS urge to 
smoke, QSU 
0.25 - - 
Hayes, et al. 
(2010) 
Anxiety Analogue / 
subclinical 
24 24 27 dot-
probe 
words neutral vertical 1 480  lab Negative 
thoughts 
intrusions, 
VAS 
depression, 
difficulty to 
worry, 
positive 
thoughts 
during worry 
period 
- 0.48 - 
Hazen, et al. 
(2009) 
Anxiety Analogue / 
subclinical 
12 12 19 dot-
probe 
words neutral vertical 5 216 6 lab BDI-II, 
PSQW, STAI-
T 
0.58 - - 
Heeren, et al. Anxiety Clinical 20 19 22 visual words neutral horizontal 1 560 not lab BASA, VAS 
anxiety, VAS 
-0.08 0.63 - 
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(2011) cueing applicable mood 
Heeren, et al. 
(2012) 
Anxiety Clinical 20 18 22 dot-
probe 
picture
s 
positive horizontal 4 744 1 lab BASA, FNES, 
LSAS, SUDS 
0.51 - 1.13 
Julian, et al. 
(2012) 
(exercise) 
Anxiety Analogue / 
subclinical 
28 28 20 dot-
probe 
picture
s 
neutral vertical 1 160 not 
applicable 
lab STAI-S 0.07 0.07  
Julian, et al. 
(2012) (rest) 
Anxiety Analogue / 
subclinical 
28 28 20 dot-
probe 
picture
s 
neutral vertical 1 160 not 
applicable 
lab STAI-S 0.41 0.26 - 
Klumpp & 
Amir (2010) 
Anxiety Analogue / 
subclinical 
31 22 20 dot-
probe 
picture
s 
neutral vertical 1 160 not 
applicable 
lab STAI-S - 0.61 - 
Kruijt, et al. 
(2013) 
Depressio
n 
Analogue / 
subclinical 
20 20  visual 
search  
picture
s 
positive matrix 1 256 not 
applicable 
lab PANAS -0.31 - - 
Li, et al. 
(2008) 
Anxiety Analogue / 
subclinical 
12 10 20 dot-
probe 
picture
s 
neutral horizontal 7 480 1 lab FNES, SIAS, 
SPS 
0.24 - - 
Mathews & 
MacLeod 
(2002) E7 
Anxiety Analogue / 
subclinical 
15 14 unsp
ecifi
ed 
dot-
probe 
words neutral vertical 10 750 unspecified lab STAI-T 1 - - 
Mathews & 
MacLeod 
(2002) E8 
Anxiety Analogue / 
subclinical 
16 14 unsp
ecifi
ed 
dot-
probe 
words neutral vertical 8 750 unspecified lab STAI-T 0.72 - - 
McHugh, et 
al. (2010) 
Substance 
abuse 
Analogue / 
subclinical 
25 26 38 dot-
probe 
picture
s 
neutral vertical 1 560  lab QSU 0.06 0.05 - 
Najmi & 
Amir (2010) 
Anxiety Analogue / 
subclinical 
26 26 19 dot-
probe 
words neutral vertical 1 288  lab BAT, STAI-S, 
VAS anxiety 
0.13 0.4 - 
Neubauer et 
al., (2013) 
Anxiety Clinical 24 24 40 dot-
probe 
picture
s 
neutral vertical 8 160 0.5 home SCID, LSAS, 
SIAS, SPS, 
BDI-II,  
0.05 - 0.003 
Reese, et al. 
(2010) 
Anxiety Analogue / 
subclinical 
21 21 26 dot-
probe 
picture
s 
neutral vertical 1 768  lab BAT, SPQ, 
SUDS, VAS 
mood 
-0.02 - - 
Schmidt, et 
al. (2009) 
Anxiety Clinical 18 18 23 dot-
probe 
picture
s 
neutral vertical 8 160 2 lab BDI-II, BSPS, 
LSAS, SCID, 
0.71 - 0.9 
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SPAI, STAI-T 
Shoenmarker
s, et al. 
(2007) 
Substance 
abuse 
Analogue / 
subclinical 
53 53 21 dot-
probe 
picture
s 
neutral horizontal 1 624  lab Preference 
task, VAS 
craving 
-0.23 - - 
Schoenmark
ers, et al. 
(2010) 
Substance 
abuse 
Clinical 21 22 45 dot-
probe 
picture
s 
neutral horizontal 5 528 2 lab DAQ, time to 
discharge, 
time to relapse 
0.04 - 1.41 
Schoorl, et 
al. (2013) 
Anxiety Clinical 38 38 37 dot-
probe 
picture
s 
neutral vertical 8 200 0.5 home CAPS, 
HADS-A, 
HADS-D, 
SRIP 
0.13 - 0.11 
See, et al. 
(2009) 
Anxiety Analogue / 
subclinical 
22 18 22 dot-
probe 
words neutral vertical 15 192 1 home STAI-S, 
STAI-T 
- 0.64 - 
Sharpe, et al. 
(2012) S1 
Pain Clinical 23 23 42 dot-
probe 
words neutral vertical 1 320  lab DASS, 
Roland-Morris 
Disability 
Questionnaire, 
Tampa Scale 
for 
Kinesiophobia
, VAS pain 
- - 0.27 
Sharpe, et al. 
(2012) S2 
Pain Clinical 17 9 47 dot-
probe 
words neutral vertical 4 320 2 home ASI, DASS, 
Roland-Morris 
Disability 
Questionnaire, 
Tampa Scale 
for 
Kinesiophobia
, VAS pain 
-0.15 - 0.02 
Taylor et al. 
(2011) 
Anxiety Analogue / 
subclinical 
43 34 19 dot-
probe 
words positive vertical 1 384  lab PA, STAI-S  0.16 - 
Tsumura, et 
al. (2012) 
Depressio
n 
Analogue / 
subclinical 
27 26 22 dot-
probe 
words neutral horizontal 1 510 not 
applicable 
lab Cortisol level, 
VAS 
depressive 
mood 
0.28 - - 
Verwoerd, et - Healthy 22 23 20 visual picture neutral horizontal 1 384  lab Impact of 
Movie Scale, 
0.82 - 0.66 
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al. (2012) participants cueing s Intrusion 
monitoring 
task, no. of 
intrusions 
(diary) 
Waters, et al. 
(2013) 
Anxiety Clinical 12 12 10 visual 
search  
picture
s 
positive matrix 12 160 5.3 home ADIS-C-IV-
C/P, SCAS-P, 
CES-DC, 
SCAS-C 
0.97 - - 
Wells & 
Beevers 
(2010) 
Depressio
n 
Analogue / 
subclinical 
14 17 19 dot-
probe 
picture
s 
neutral horizontal 4 196 2 lab BDI-II 0.31 - 0.96 
Notes: Hedge’s g indexes change on symptoms, and combines all the computed effect sizes, irrespective of outcome measures. E = experiment; S = study; ADIS = Anxiety Disorders Interview 
Shedule (Brown, Dinardo, & Barlow, 1994); ASI = Anxiety Sensitivity Index (Reiss et al., 1986); BAI = Beck Anxiety Inventory (Beck, Epstein, Brown, & Steer, 1988); BARS = Behavioral 
Avoidance rating Scale (Beidel et al., 2007); BASA = Behavioral Assessment of Speech Anxiety (Mulac & Sherman, 1974); BAT = Behavioral Approach Test; BDI-II = Beck Depression 
Inventory-II (Beck, Steer, & Brown, 1996); BSI = Brief Symptom Inventory (Derogatis & Melisaratos, 1983); BSPS = Brief Social Phobia Scale (Davidson et al., 1991); CAR = cortisol 
awaking response; CAPS = Clinician-Administered PTSD Scale (Blake et al., 1990); CDI = Children’s Depression Inventory (Kovacs, 1985); CES-DC = Center for Epidemiologic Depression 
Studies for Children (Weissman et al., 1980); CGI = Clinical Global Impression of Improvement (Guy, 1976); CIQ = Cognitive Interference Questionnaire (Sarason & Stroops, 1978); DAQ = 
Desires for Alcohol Questionnaire (Love et al., 1998); DASS = Depression, Anxiety, and Stress Scale (Lovibond & Lovibond, 1995); ERP-N2, ERP-P2, ERP-P3 = event-related potential N2, 
P2, P3; FNES = Fear of Negative Evaluation Scale (Watson & Friend, 1969); HADS = Hospital Anxiety and Depression Scale (Zigmond & Shaith, 1983); HAM-D = Hamilton Rating Scale 
for Depression (Hamilton, 1960); HRSA = Hamilton Rating Scale for Anxiety (Hamilton, 1959); IST = Impromptu Speech Task (Beidel et al., 2010); LSAS = Liebowitz Social Anxiety Scale 
(Liebowitz, 1987); MASQ = Mood and Anxiety Symptoms Questionnaire (Watson & Clacrk, 1991); PA = Positive Affect;POMS-SF = Short-form of the Profile of Mood States (Curran, 
Andykowsky, & Studts, 1995); PSQW = Penn State Worry Questionnaire (Meyer et al., 1990); QSU = Questionnaire on smoking urges (Cox et al., 2001); RRS = Ruminative Responses Scale 
(Nolen-Hoeksema & Morrow, 1991); QOLI = Quality of Life Inventory (Frish et al., 1992); SCID = Structured Clinical Interview for DSM-IV (First, Spitzer, Gibbons, & Williams, 2001); 
SES = State Self-esteem Scale (Heatherton & Polivy, 1991); SDS = Sheehan Disability Scale (Leon, Olfson, Portera, Faber, & Sheenan, 1997); SCAS = Spence Childre Anxiety Scale (Spence, 
1998); SIAS = Social Interaction Anxiety Scale (Mattick & Clarke, 1998); SPQ = Spider Questionnaire (Klorman et al., 1974); SPS = Social Phobia Scale (Mattick & Clarke, 1998); SPSQ = 
Social Pshobia Screening Questionnaire (Furmak et al., 1999); SRIP = Self-Rating Inventory for Posttraumatic Stress Disorder (Hovens et al., 2005); STAI-C = State-Trait Anxiety Inventory 
for Children (Spielberger, Edwards, Lushene, Montuori, & Platzek, 1973); STAI-S/ STAI-T = State-Trait Anxiety Inventory-State/State-Trait Anxiety Inventory-Trait (Spielberger, Gorsuch, 
Lushene, Vagg, & Jacobs, 1983); SUDS = Subjective Units of Discomfort Scale (Wolpe, 1958); UCT = Unstructured Conversation Task (Turner et al., 1994); VAS = visual analogue scale; 
WDQ = Worry Domains Questionnaire (Tallis, Eysenck, & Mathews, 1992). 
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Table 2. ABM effect on symptoms across symptom categories 
 
    Post intervention     Post-stressor    Follow-up 
Symptom 
category 
k Hedges's 
g 
95% CI Q within I²   k Hedges's 
g 
95% CI Q 
within 
I²   k Hedges's 
g 
95% CI Q within I² 
Anxiety 22 0.26 [0.132; 
0.388] 
95.678,   
p = 0.000 
78.051  11 0.337 [0.206; 
0.468] 
14.119,  
p = 0.168 
29.171  5 0.216 [-0.108; 
0.539] 
40.079,  
p = 0.000 
90.02 
Depression 7 -0.106 [0.382; 
0.169] 
32.519,   
p = 0.000 
81.549  0 - - - -  2 0.161 [-1.245; 
1.567] 
6.881,    
p = 0.009 
85.466 
Distress 
(measured in 
healthy 
participants)* 
4 0.211 [0.046; 
0.375] 
1.420,     
p = 0.701 
0  1 0.511 [0.152; 
0.870] 
- -  1 0.661 [0.235; 
1.086] 
- - 
Pain 1 -0.149 [0.421; 
0.122] 
- -  0 - - - -  1 0.273 [0.033; 
0.513] 
- - 
Substance 
Abuse 
5 0.003 [0.155; 
0.161] 
4.853,     
p = 0.303 
17.569   1 0.055 [-0.494; 
0.605] 
- -   0 - - - - 
 
Notes: k = number of studies; *Verwoerd et al. (2012) was eliminated as outlier 
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Table 3. Categorical moderators of the ABM effect on symtoms in anxiety studies 
 
  Post intervention   Post stressor 
Moderator variable g 95 % CI Qwithin Qbetween  g 95 % CI Qwithin Qbetween 
Type of anxiety 
symptoms* 
Generalized anxiety 0.607 [0.426, 
0.789] 
Q(3) = 0.472,     
p = 0.925 
Q(2) = 10.753, 
p = 0.005 
  0.484 [-0.091; 
1.060] 
Q(0) = 0.000,     
p = 1.000 
Q(2) = 0.123,    
p = 0.940 
Social anxiety 0.24 [0.052; 
0.428] 
Q(12) = 61.739, 
p = 0.000 
  0.378 [0.206; 
0.550] 
Q(6) = 5.575,    
p = 0.472 
Others 0.162 [-0.104, 
0.428] 
Q(4) = 12.608,     
p = 0.013 
  0.395 [0.159; 
0.631] 
Q(2) = 1.609,   
p = 0.447 
Clinical status Diagnosed 0.291 [0.095, 
0.488] 
Q(11) = 75.224,  
p = 0.000 
Q(1) = 0.033,    
p = 0.855 
  0.399 [-0.168, 
0.966] 
Q(1) = 1.879,     
p = 0.170 
Q(1) = 0.004,    
p = 0.951 
Analogue sample 0.265 [0.062, 
0.469] 
Q(9) = 11.479,    
p = 0.021 
  0.381 [0.236, 
0.525] 
Q(8) = 5.306,     
p = 0.724 
Type of training Towards neutral 0.282 [0.129, 
0.435] 
Q(19) = 94.652,  
p = 0.000 
Q(1) = 0.133,    
p = 0.715 
  0.412 [0.270, 
0.554] 
Q(9) = 6.237     
p = 0.716 
Q(1) = 1.070,    
p = 0.301 
  Towards positive 0.337 [0.083, 
0.592] 
Q(1) = 273,       
p = 0.601 
  0.163 [-0.288, 
0.613] 
 Q(0) = 0.000,    
p = 1.000 
Type of training 
stimuli 
Pictures 0.254 [0.105, 
0.403] 
Q(18) = 82.829,  
p = 0.000 
Q(1) = 2.940,    
p = 0.086 
  0.389 [0.210, 
0.568] 
Q(6) = 5.618,   
p = 0.467 
Q(1) = 0.000,      
p = 0.993 
Words 0.53 [0.252, 
0.807] 
Q(2) = 2.825,     
p = 0.244 
  0.39 [0.185, 
0.596] 
Q(3) = 1.689,     
p = 0.639 
Training task Dot-probe 0.319 [0.171, 
0.467] 
Q(19) = 90.602, 
p = 0.000 
Q(1) = 6.179,    
p = 0.013 
  0.382 [0.237, 
0.526] 
Q(8) = 5.247,   
p = 0.731 
Q(1) = 0.001,    
p = 0.973 
Visual cueing -0.135 [-0.462, 
0.191] 
Q(1) = 0.133,     
p = 0.715 
  0.392 [-0.176, 
0.959] 
Q(1) = 1.968,     
p = 0.161 
Training setting Lab 0.369 [0.213, 
0.524] 
Q(17) = 59.922,  
p = 0.000 
Q(1) = 13.461,          
p = 0.000 
  0.378 [0.240, 
0.516] 
Q(9) = 6.684,     
p = 0.670 
Q(1) = 0.623,    
p = 0.430 
Home -0.015 [-0.148, 
0.119] 
Q(3) = 4.545,    
p = 0.208 
  0.642 [0.001, 
1.282] 
Q(0) = 0.000,     
p = 1.000 
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Stimuli 
presentation 
during training 
Horizontal 0.3 [0.022, 
0.577] 
Q(5) = 14.630,    
p = 0.012 
Q(1) = 0.015,  
p = 0.902 
  0.392 [-0.176, 
0.959] 
Q(1) = 1.968,   
p = 0.161 
Q(1) = 0.001,    
p = 0.973 
Vertical 0.285 [0.142, 
0.428] 
Q(15) = 78.738,  
p = 0.000 
  0.382 [0.237, 
0.526] 
Q(8) = 5.247,     
p = 0.731 
Nature of 
dependent 
variable 
Self-report 
measures 
0.131 [-0.000, 
0.263] 
Q(18) = 11.384,  
p = 0.877 
Q(2) = 4.573,    
p = 0.102 
  0.311 [0.141, 
0.480] 
Q(9) = 5.541,   
p = 0.785 
Q(1) = 1.941,   
p = 0.164 
Clinician-rated 
measures 
0.385 [0.152, 
0.617] 
Q(9) = 14.046,  
p = 0.121 
  - - - 
Bio-behavioral 
measures 
0.634 [-0.173, 
1.441] 
Q(2) = 8.327,    
p = 0.016 
  0.527 [0.274, 
0.780] 
Q(3) = 3.545,   
p = 0.315 
Primary versus 
secondary 
outcome** 
Primary outcome 0.314 [0.188, 
0.441] 
Q(20) = 19.451, 
p = 0.493 
Q(1) = 7.259,    
p = 0.007 
  0.369 [0.201, 
0.538] 
Q(9) = 7.233,  
p = 0.613 
Q(1) = 6.214,    
p = 0.013 
Secondary outcome 0.033 [-0.128, 
0.194] 
Q(12) = 11.691,  
p = 0.471 
  -0.256 [-0.718, 
0.206] 
Q(1) = 7.383,     
p = 0.689 
Notes: *"Generalized anxiety" symptom category included studies conducted with diagnosed participants, as well as with high anxiety individuals and high worriers; 'Others" 
symptoms category included phobias and post-traumatic stress disorder, as well as undifferentiated/comorbid symptoms of anxiety (see Eldar et al. 2012; Bar-Haim et al., 
2011) ;**For this moderator we used outcomes subgroup within the study as the unit of analysis. For the other categorical moderators, study was used as the unit of analysis.
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Figure 1. Studies’ flow chart 
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(n = 994) 
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(n = 994 ) 
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(n = 908) 
Full-text articles assessed 
for eligibility 
(n =  86 ) 
Full-text articles excluded, 
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(n =  46) 
 No control condition   
(n = 20) 
 Intervention did not 
amend AB (n = 5) 
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studies (n = 10) 
 No randmized studies 
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Studies included in 
quantitative synthesis 
(meta-analysis) 
 Articles: n = 40 
 Studies: n = 44 
 Group comparisons:   
n = 47 
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Appendix A 
Coding Categories for Dependent Variables: Primary versus Secondary Outcomes 
 
Type of outcome Symptom category Measures 
Primary outcomes Generalized 
Anxiety/high 
worriers/high anxiety 
Anxiety severity scale, anxiety symptoms count, SCAS, SCID, HRSA, PSWQ, 
WDQ, STAI-S, STAI-T, STAIC, negative thoughts intrusions 
Social anxiety ADIS, BA, BARS, BASA, BSI, BSPS, CGI, FNES, IST, LSAS, SCID, SDS, 
SIAS, SPAI, SPS, SPSQ, SUDS, UCT 
Spider Phobia BAT, SPQ, SUDS 
PTSD CAPS, SRIP, Impact of Movie Scale, Intrusion monitoring task, no. of 
intrusions (daily diary) 
OCD symptoms BAT 
Depression BDI-II, CAR, HAM-D, RRS, POMS depression, MASQ-GDD, MASQ-AD, 
MASQ-GDM 
Alcohol consumption Amount of beer consumed, DAQ, VAS urge to drink, preference task, time to 
discharge, time to relapse 
Smoking QSU, VAS craving, choose to smoke, amount willing to pay, delay discounting, 
VAS urge to smoke 
Pain Roland-Morris Disability Questionnaire, Tampa Scale for Kinesiophobia, VAS  
Secondary 
outcomes 
ASI, BAI, BDI-II, STAI, CDI, CES-DC, HADS, MASQ-GD, MASQ-GDA, MASQ-AA, POMS anger, 
POMS fatigue, POMS vigor, POMS tension, QOLI, VAS anxiety, VAS mood, DASS, PA 
 
Notes: ADIS = Anxiety Disorders Interview Shedule (Brown, Dinardo, & Barlow, 1994); ASI = Anxiety Sensitivity Index (Reiss et al., 1986); BAI = Beck 
Anxiety Inventory (Beck, Epstein, Brown, & Steer, 1988); BARS = Behavioral Avoidance rating Scale (Beidel et al., 2007); BASA = Behavioral Assessment 
of Speech Anxiety (Mulac & Sherman, 1974); BAT = Behavioral Approach Test; BDI-II = Beck Depression Inventory-II (Beck, Steer, & Brown, 1996); BSI = 
Brief Symptom Inventory (Derogatis & Melisaratos, 1983); BSPS = Brief Social Phobia Scale (Davidson et al., 1991); CAR = cortisol awaking response; 
CAPS = Clinician-Administered PTSD Scale (Blake et al., 1990); CDI = Children’s Depression Inventory (Kovacs, 1985); CES-DC = Center for 
Epidemiologic Depression Studies for Children (Weissman et al., 1980); CGI = Clinical Global Impression of Improvement (Guy, 1976); CIQ = Cognitive 
Interference Questionnaire (Sarason & Stroops, 1978); DAQ = Desires for Alcohol Questionnaire (Love et al., 1998); DASS = Depression, Anxiety, and Stress 
Scale (Lovibond & Lovibond, 1995); ERP-N2, ERP-P2, ERP-P3 = event-related potential N2, P2, P3; FNES = Fear of Negative Evaluation Scale (Watson & 
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Friend, 1969); HADS = Hospital Anxiety and Depression Scale (Zigmond & Shaith, 1983); HAM-D = Hamilton Rating Scale for Depression (Hamilton, 1960); 
HRSA = Hamilton Rating Scale for Anxiety (Hamilton, 1959); IST = Impromptu Speech Task (Beidel et al., 2010); LSAS = Liebowitz Social Anxiety Scale 
(Liebowitz, 1987); MASQ = Mood and Anxiety Symptoms Questionnaire (Watson & Clacrk, 1991); PA = Positive Affect;POMS-SF = Short-form of the 
Profile of Mood States (Curran, Andykowsky, & Studts, 1995); PSQW = Penn State Worry Questionnaire (Meyer et al., 1990); QSU = Questionnaire on 
smoking urges (Cox et al., 2001); RRS = Ruminative Responses Scale (Nolen-Hoeksema & Morrow, 1991); QOLI = Quality of Life Inventory (Frish et al., 
1992); SCID = Structured Clinical Interview for DSM-IV (First, Spitzer, Gibbons, & Williams, 2001); SES = State Self-esteem Scale (Heatherton & Polivy, 
1991); SDS = Sheehan Disability Scale (Leon, Olfson, Portera, Faber, & Sheenan, 1997); SCAS = Spence Childre Anxiety Scale (Spence, 1998); SIAS = 
Social Interaction Anxiety Scale (Mattick & Clarke, 1998); SPQ = Spider Questionnaire (Klorman et al., 1974); SPS = Social Phobia Scale (Mattick & Clarke, 
1998); SPSQ = Social Pshobia Screening Questionnaire (Furmak et al., 1999); SRIP = Self-Rating Inventory for Posttraumatic Stress Disorder (Hovens et al., 
2005); STAI-C = State-Trait Anxiety Inventory for Children (Spielberger, Edwards, Lushene, Montuori, & Platzek, 1973); STAI-S/ STAI-T = State-Trait 
Anxiety Inventory-State/State-Trait Anxiety Inventory-Trait (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983); SUDS = Subjective Units of Discomfort 
Scale (Wolpe, 1958); UCT = Unstructured Conversation Task (Turner et al., 1994); VAS = visual analogue scale; WDQ = Worry Domains Questionnaire 
(Tallis, Eysenck, & Mathews, 1992). 
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Appendix B 
Coding Categories for Dependent Measures: Self-report, Clinician-rated, and Bio-behavioral Measures 
 
Type of outcome Measures 
Bio-behavioral BA, BAT, BASA, cbehavioral preferences, confidence rated by other, ERP-N2, ERP-P2, ERP-P3, CAR,  choose 
to smoke, cortisol index, cortisol reactivity, delay discounting, HF, LF, HF/LF ratio, IST, mean bear 
consumption,  RMSSD, speech performance, time to relapse, UCT 
Clinician-rated ADIS, BSPS, Anxiety severity scale, anxiety symptoms count, CAPS, CGI, LSAS (clinician-rated), HRSA, 
HAM-D, SCID, SDS, time to discharge 
Self-report ASI, BAI, LSAS (self-report), STAI-S, STAI-T, BDI-II, SPAI, WDQ, MASQ, PSWQ, POMS-SF, RRS, QSU, 
VAS craving, VAS urge to smoke/drink, VAS anxiety, VAS deprression, SIAS, FNES, SPS, SPQ, DAQ, CDI, 
STAI-C, amount willing to pay for a cigarette, VAS feelings of rejection, SES, CIQ, QOLI, school abilities self-
esteem, negative thoughts intrusions, difficulty to worry, positie thoughts during worry perios, SUDS, VAS 
pain, DASS, Roland-Morris Disability Questionnaire, Tampa Scale for Kinesiophobia, PANAS, Impact of 
Movie Scale, intrusions monitoring task, number of intrusions, SRIP, CES-DC, SCAS 
 
Notes: ADIS = Anxiety Disorders Interview Shedule (Brown, Dinardo, & Barlow, 1994); ASI = Anxiety Sensitivity Index (Reiss et al., 1986); BAI = Beck 
Anxiety Inventory (Beck, Epstein, Brown, & Steer, 1988); BARS = Behavioral Avoidance rating Scale (Beidel et al., 2007); BASA = Behavioral Assessment 
of Speech Anxiety (Mulac & Sherman, 1974); BAT = Behavioral Approach Test; BDI-II = Beck Depression Inventory-II (Beck, Steer, & Brown, 1996); BSI = 
Brief Symptom Inventory (Derogatis & Melisaratos, 1983); BSPS = Brief Social Phobia Scale (Davidson et al., 1991); CAR = cortisol awaking response; 
CAPS = Clinician-Administered PTSD Scale (Blake et al., 1990); CDI = Children’s Depression Inventory (Kovacs, 1985); CES-DC = Center for 
Epidemiologic Depression Studies for Children (Weissman et al., 1980); CGI = Clinical Global Impression of Improvement (Guy, 1976); CIQ = Cognitive 
Interference Questionnaire (Sarason & Stroops, 1978); DAQ = Desires for Alcohol Questionnaire (Love et al., 1998); DASS = Depression, Anxiety, and Stress 
Scale (Lovibond & Lovibond, 1995); ERP-N2, ERP-P2, ERP-P3 = event-related potential N2, P2, P3; FNES = Fear of Negative Evaluation Scale (Watson & 
Friend, 1969); HADS = Hospital Anxiety and Depression Scale (Zigmond & Shaith, 1983); HAM-D = Hamilton Rating Scale for Depression (Hamilton, 1960); 
HF = high frequency (HRV indicator); HRSA = Hamilton Rating Scale for Anxiety (Hamilton, 1959); IST = Impromptu Speech Task (Beidel et al., 2010); LF 
= low frequency (HRV indicator); LSAS = Liebowitz Social Anxiety Scale (Liebowitz, 1987); MASQ = Mood and Anxiety Symptoms Questionnaire (Watson 
& Clacrk, 1991); PA = Positive Affect;POMS-SF = Short-form of the Profile of Mood States (Curran, Andykowsky, & Studts, 1995); PSQW = Penn State 
Worry Questionnaire (Meyer et al., 1990); QSU = Questionnaire on smoking urges (Cox et al., 2001); RRS = Ruminative Responses Scale (Nolen-Hoeksema 
& Morrow, 1991); QOLI = Quality of Life Inventory (Frish et al., 1992); RMSSD = root mean square of the differences of succesive intervals (heart rate 
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variability - HRV indicator); SCID = Structured Clinical Interview for DSM-IV (First, Spitzer, Gibbons, & Williams, 2001); SES = State Self-esteem Scale 
(Heatherton & Polivy, 1991); SDS = Sheehan Disability Scale (Leon, Olfson, Portera, Faber, & Sheenan, 1997); SCAS = Spence Childre Anxiety Scale 
(Spence, 1998); SIAS = Social Interaction Anxiety Scale (Mattick & Clarke, 1998); SPQ = Spider Questionnaire (Klorman et al., 1974); SPS = Social Phobia 
Scale (Mattick & Clarke, 1998); SPSQ = Social Pshobia Screening Questionnaire (Furmak et al., 1999); SRIP = Self-Rating Inventory for Posttraumatic Stress 
Disorder (Hovens et al., 2005); STAI-C = State-Trait Anxiety Inventory for Children (Spielberger, Edwards, Lushene, Montuori, & Platzek, 1973); STAI-S/ 
STAI-T = State-Trait Anxiety Inventory-State/State-Trait Anxiety Inventory-Trait (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983); SUDS = Subjective 
Units of Discomfort Scale (Wolpe, 1958); UCT = Unstructured Conversation Task (Turner et al., 1994); VAS = visual analogue scale; WDQ = Worry Domains 
Questionnaire (Tallis, Eysenck, & Mathews, 1992). 
 
 
 
